in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
. the software can help physicians administer emergency treatment more quickly and also predict the one's chances of developing dementia.
labourís new study is based on freedom of information data from 95 english nhs trust.